• 23. Dezember 2024

ISA Pharmaceuticals and Scancell enter collaboration agreement for the manufacturing, development and commercialisation of Modi-1 / AMPLIVANT® combination

ByISA Pharmaceuticals

Feb 15, 2018
— AMPLIVANT-Modi-1 conjugate expected to enter clinic in H1 2019
— Collaboration seeks to further leverage Moditope® platform

Teile den Beitrag mit Freunden